Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 TrialHelena W. Rodbard, Е. О. Филиппова, Pablo Jordão Alcântara Cruz et al.|Diabetes Care|2019Cited by 442
The ORlistat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORliCARDIA) studyTriantafyllos Didangelos, Dimitrios T. Karamitsos, Anastasia Thanopoulou et al.|Current Medical Research and Opinion|2004Cited by 70
Insulin Receptors and Insulin Action in the Heart: The Effects of Left Ventricular Assist DevicesKonstantina Pantazi, Triantafyllos Didangelos, Eleni Karlafti et al.|Biomolecules|2022Cited by 17
Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative reviewChristos Nikolaidis, Anastasia Thanopoulou, Despoina Gyriki et al.|Frontiers in Immunology|2025Cited by 4
Modulating the Gut Microbiome in Type 2 Diabetes: Nutritional and Therapeutic StrategiesChristos Nikolaidis, Anastasia Thanopoulou, Despoina Gyriki et al.|Nutrients|2025Cited by 4